Hancock Whitney Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Hancock Whitney Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $1.17 Million - $1.72 Million	-19,045 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$43.82 - $85.37 $132,336 - $257,817	-3,020 Reduced 13.69%	19,045 $1.46 Million
Q3 2020 Nov 05, 2020	SELL	$33.21 - $51.27 $42,641 - $65,830	-1,284 Reduced 5.5%	22,065 $950,000
Q2 2020 Jul 30, 2020	SELL	$26.12 - $43.27 $134,021 - $222,018	-5,131 Reduced 18.02%	23,349 $1.01 Million
Q1 2020 May 08, 2020	BUY	$20.56 - $63.12 $12,336 - $37,872	600 Added 2.15%	28,480 $819,000

Q4 2019 Feb 06, 2020	BUY	$28.14 - $73.01 $784,543 - $2.04 Million	27,880 New	27,880 $1.77 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.